Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Piptaz 4 g / 500 mg

Piptaz 4 g / 500 mg is a medicine containing the active ingredient(s) piperacillin + tazobactam. On this page you will find out more about Piptaz 4 g / 500 mg, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: piperacillin + tazobactam

Information for medicine and pack size:
Piptaz 4 g / 500 mg powder for injection, 10 x 4.5 g vials

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

Piperacillin and tazobactam is indicated in the treatment of serious bacterial infections caused by susceptible strains of beta-lactamase producing organisms in the conditions listed below: Lower respiratory tract infections; Urinary tract infections (complicated and uncomplicated); Intra-abdominal infections; Skin and skin structure infections; Bacterial septicaemia; and Gynaecological infections. Children under the age of 12 years: In hospitalised children aged 2 to 12 years, Piperacillin and tazobactam is indicated for the treatment of serious intra-abdominal infections. It has not been evaluated in this indication for paediatric patients below the age of two years. While Piperacillin and tazobactam is indicated only for the conditions listed above, it may be used as a single agent in the treatment of mixed infections caused by Piperacillin susceptible and beta-lactamase producing, piperacillin resistant organisms. Appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to Piperacillin and tazobactam. Therapy with Piperacillin and tazobactam, however, may be initiated before results of such tests are known when there is reason to believe the infection may involve any of the beta-lactamase producing organisms listed above; however, once results become available, appropriate therapy should be continued. In serious infections, presumptive therapy with Piperacillin and tazobactam may be initiated before susceptibility test results are available. Combination therapy with Piperacillin and tazobactam and aminoglycosides may be used in the treatment of serious infections caused by Pseudomonas aeruginosa. Both drugs should be used in full therapeutic doses. As soon as results of culture and susceptibility tests become available, antimicrobial therapy should be adjusted.

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance white or almost white lyophilized powder
Dosage Form Injection, powder for
Route of administration Intravenous
Medicine schedule
10 x 50 mL vials: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Vial
Storage temperature Store below 25 degrees Celsius
Storage conditions No information available
Life time 3 Years
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Found 150 results

Janumet 50 mg/500 mg tablets - myDr.com.au

Janumet 50 mg/500 mg tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Trajentamet 2.5 mg/500 mg Tablets - myDr.com.au

Trajentamet 2.5 mg/500 mg Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Nesina Met 12.5 mg/500 mg Tablets - myDr.com.au

Nesina Met 12.5 mg/500 mg Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Kombiglyze XR 5 mg/500 mg Modified release tablets - myDr.com.au

Kombiglyze XR 5 mg/500 mg Modified release tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Piptaz Powder for infusion - myDr.com.au

Piptaz Powder for infusion - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Avandamet 2/500 Tablets - myDr.com.au

Avandamet 2/500 Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Janumet XR 50 mg/1000 mg tablets - myDr.com.au

Janumet XR 50 mg/1000 mg tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

What you need to know about Osteoporosis

1.2 million Australians are affected by osteoporosis, which means that their bones are fragile and at risk of fracture. A further 6.3 million people have low bone density (osteopenia), a possible precursor to osteoporosis. However, as many as 4 out of 5 people with osteoporosis don’t know that they have it and therefore don’t know that they are at risk of fracturing a bone. This is because osteoporosis is a ‘silent’ disease without obvious symptoms.

Read more on Osteoporosis Australia website

Erythrocin IV | myVMC

Erythrocin is an antibiotic medicine used to treat bacterial infections including syphilis and otitis media. It contains erythromycin.

Read more on myVMC – Virtual Medical Centre website

Pro-Cid | myVMC

Pro-cid is a medicine used to prevent gout and to treat bacterial infections (in conjunction with antibiotics) and HIV (in conjunction with cidofovir).

Read more on myVMC – Virtual Medical Centre website

Check your symptoms Find a health service

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback